AiViva Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- AiViva Biopharma's estimated annual revenue is currently $2.8M per year.
- AiViva Biopharma's estimated revenue per employee is $155,000
Employee Data
- AiViva Biopharma has 18 Employees.
- AiViva Biopharma grew their employee count by 6% last year.
AiViva Biopharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, CEO & President | Reveal Email/Phone |
2 | Executive Assistant to President & CEO | Reveal Email/Phone |
3 | VP Clinical Development | Reveal Email/Phone |
4 | VP Business Development | Reveal Email/Phone |
5 | Exe. Director, Pre-clinical | Reveal Email/Phone |
6 | Executive Director, Medical Sciences | Reveal Email/Phone |
7 | Director, Platform Research | Reveal Email/Phone |
AiViva Biopharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is AiViva Biopharma?
AiViva BioPharma, Inc. is a privately owned clinical stage biotech developing novel technologies to address unmet medical needs by transforming existing treatments to create localized, targeted treatment of diseases while limiting systemic exposure. Our core competency includes development of drugs using our proprietary JELâ„¢ Technology in specialty therapeutic areas of Dermatology, Ophthalmology, Urology, and Oncology.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | -18% | N/A |
#2 | $1.6M | 18 | -25% | N/A |
#3 | $1.4M | 18 | 0% | N/A |
#4 | $0.8M | 18 | 0% | $7M |
#5 | $2.9M | 19 | -5% | N/A |